TRENTON, N.J. (AP) — U.S. regulators want to know why Novartis didn’t disclose a problem with testing data until after the Swiss drugmaker’s $2.1 million gene therapy was approved. The Food and Drug Administration said the manipulated data involves testing of the therapy on animals, not on patients. The FDA on Tuesday said it’s confident […]
